Lawrence Biegelsen
Stock Analyst at Wells Fargo
(1.36)
# 3,137
Out of 4,818 analysts
50
Total ratings
45.16%
Success rate
-7.51%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Lawrence Biegelsen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ABT Abbott Laboratories | Maintains: Overweight | $136 → $147 | $129.82 | +13.23% | 5 | Apr 17, 2025 | |
| PODD Insulet | Maintains: Overweight | $305 → $322 | $246.79 | +30.48% | 4 | Feb 21, 2025 | |
| NPCE NeuroPace | Upgrades: Overweight | $16 → $20 | $10.93 | +82.98% | 7 | Mar 14, 2024 | |
| TNDM Tandem Diabetes Care | Maintains: Overweight | $166 → $82 | $16.57 | +394.87% | 5 | Aug 4, 2022 | |
| TFX Teleflex | Downgrades: Equal-Weight | $248 | $133.00 | +86.47% | 1 | Jul 29, 2022 | |
| BDX Becton, Dickinson and Company | Upgrades: Overweight | $275 | $202.51 | +35.80% | 4 | Jun 24, 2022 | |
| ISRG Intuitive Surgical | Maintains: Overweight | $350 → $339 | $487.93 | -30.52% | 2 | Apr 22, 2022 | |
| REE REE Automotive | Initiates: Underweight | $1.5 | $2.64 | -43.18% | 1 | Mar 25, 2022 | |
| LUNG Pulmonx | Maintains: Equal-Weight | $55 → $27 | $4.98 | +442.17% | 3 | Feb 24, 2022 | |
| ZBH Zimmer Biomet Holdings | Maintains: Underweight | $124 → $111 | $99.54 | +11.51% | 2 | Feb 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $144 | $67.25 | +113.75% | 1 | Jan 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $56 | $92.61 | -39.53% | 4 | Jan 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $68 → $74 | $93.79 | -21.10% | 6 | Oct 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $77 | $70.46 | +8.81% | 3 | Apr 28, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $85 → $90 | $17.70 | +408.62% | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | n/a | $71.90 | - | 1 | Dec 12, 2019 |
Abbott Laboratories
Apr 17, 2025
Maintains: Overweight
Price Target: $136 → $147
Current: $129.82
Upside: +13.23%
Insulet
Feb 21, 2025
Maintains: Overweight
Price Target: $305 → $322
Current: $246.79
Upside: +30.48%
NeuroPace
Mar 14, 2024
Upgrades: Overweight
Price Target: $16 → $20
Current: $10.93
Upside: +82.98%
Tandem Diabetes Care
Aug 4, 2022
Maintains: Overweight
Price Target: $166 → $82
Current: $16.57
Upside: +394.87%
Teleflex
Jul 29, 2022
Downgrades: Equal-Weight
Price Target: $248
Current: $133.00
Upside: +86.47%
Becton, Dickinson and Company
Jun 24, 2022
Upgrades: Overweight
Price Target: $275
Current: $202.51
Upside: +35.80%
Intuitive Surgical
Apr 22, 2022
Maintains: Overweight
Price Target: $350 → $339
Current: $487.93
Upside: -30.52%
REE Automotive
Mar 25, 2022
Initiates: Underweight
Price Target: $1.5
Current: $2.64
Upside: -43.18%
Pulmonx
Feb 24, 2022
Maintains: Equal-Weight
Price Target: $55 → $27
Current: $4.98
Upside: +442.17%
Zimmer Biomet Holdings
Feb 8, 2022
Maintains: Underweight
Price Target: $124 → $111
Current: $99.54
Upside: +11.51%
Jan 19, 2022
Upgrades: Overweight
Price Target: $144
Current: $67.25
Upside: +113.75%
Jan 19, 2022
Upgrades: Equal-Weight
Price Target: $56
Current: $92.61
Upside: -39.53%
Oct 29, 2021
Maintains: Equal-Weight
Price Target: $68 → $74
Current: $93.79
Upside: -21.10%
Apr 28, 2020
Downgrades: Equal-Weight
Price Target: $77
Current: $70.46
Upside: +8.81%
Mar 5, 2020
Upgrades: Overweight
Price Target: $85 → $90
Current: $17.70
Upside: +408.62%
Dec 12, 2019
Upgrades: Overweight
Price Target: n/a
Current: $71.90
Upside: -